搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
23 小时
Teva Pharmaceutical: 2025 Guidance Sinks The Stock, But Presents An Opportunity
Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...
verywellhealth
21 小时
Can You Outgrow Asthma?
The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...
pharmaphorum
16 小时
Abingworth 'will launch $1.5bn fund for co-developed drugs'
albuterol sulfate. The drug – delivered using a proprietary Teva inhaler – could become the first ICS/SABA for both the adult and paediatric asthma population, according to the two companies.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Black boxes recovered
Los Angeles wildfire updates
Cause of death revealed
Asteroid may hit Earth
Nashville bids for franchise
Ex-worker admits to theft
Olympic gold medalist dies
Top leaders asked to resign
Michigan priest loses license
Confirmed interior secretary
Activists call for boycott
Searching for joyriders
Shiffrin finishes 10th
Hamas confirms death
US inflation ticked higher
To raise hourly pay
Recuses self from Act 10 suit
FDA approves painkiller
Inmate's transfer blocked
'As Tears Go By' singer dies
Apologizes for old tweets
Blames DEI for crash
2 more victims in indictment
Weekly jobless claims fall
Deputy shooting sentence
DOJ sues to block deal
Sexual misconduct accusation
Granted legal personhood
Ground stop amid IT outage
反馈